Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2026-01-02 @ 12:11 PM
Study NCT ID:
NCT05246293
Status:
UNKNOWN
Last Update Posted:
2023-04-27
First Post:
2022-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tofacitinib in the Treatment of Rheumatoid Arthritis-related Interstitial Lung Disease.
Sponsor:
National Institute of Respiratory Diseases, Mexico
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
C17-21
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None